Skip to main content

Cellectis S.A.

CLLS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001627281

No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in Cellectis S.A. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
36
+2 vs. Q1 2023
Shares held
14.0M
−1.19M (−7.8%) vs. Q1 2023
Total value
$27.6M
−$1.70M (−5.8%) vs. Q1 2023
New holders
7
3 more added
Sold out
5
11 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 36 institutions
Q1 2021: 81 institutionsQ2 2021: 78 institutionsQ3 2021: 70 institutionsQ4 2021: 57 institutionsQ1 2022: 51 institutionsQ2 2022: 45 institutionsQ3 2022: 50 institutionsQ4 2022: 40 institutionsQ1 2023: 34 institutionsQ2 2023: 36 institutionsQ3 2023: 31 institutionsQ4 2023: 34 institutionsQ1 2024: 31 institutionsQ2 2024: 27 institutionsQ3 2024: 27 institutionsQ4 2024: 29 institutionsQ1 2025: 27 institutionsQ2 2025: 24 institutionsQ3 2025: 28 institutionsQ4 2025: 34 institutionsQ1 2026: 32 institutionsQ2 2026: 27 institutions
Value heldQ2 2023: $27.6M
Q1 2021: $309.6MQ2 2021: $252.6MQ3 2021: $194.1MQ4 2021: $126.7MQ1 2022: $56.4MQ2 2022: $30.7MQ3 2022: $23.6MQ4 2022: $18.3MQ1 2023: $29.3MQ2 2023: $27.6MQ3 2023: $18.1MQ4 2023: $30.5MQ1 2024: $26.6MQ2 2024: $18.3MQ3 2024: $20.9MQ4 2024: $23.0MQ1 2025: $16.9MQ2 2025: $17.9MQ3 2025: $23.7MQ4 2025: $51.1MQ1 2026: $32.5MQ2 2026: $28.4M
Institutions holding CLLS and their total value by quarter
QuarterHoldersValue
Q2 202627$28.4M
Q1 202632$32.5M
Q4 202534$51.1M
Q3 202528$23.7M
Q2 202524$17.9M
Q1 202527$16.9M
Q4 202429$23.0M
Q3 202427$20.9M
Q2 202427$18.3M
Q1 202431$26.6M
Q4 202334$30.5M
Q3 202331$18.1M
Q2 202336$27.6M
Q1 202334$29.3M
Q4 202240$18.3M
Q3 202250$23.6M
Q2 202245$30.7M
Q1 202251$56.4M
Q4 202157$126.7M
Q3 202170$194.1M
Q2 202178$252.6M
Q1 202181$309.6M

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q1 2023.

Institutions holding CLLS in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Long Focus Capital Management, LLC4,487,293$8.84M1.34%00.0%Unchanged
Bpifrance SA2,186,960$4.30M0.12%00.0%Unchanged
Capital International Investors1,848,804$3.64M0.00%00.0%Unchanged
Credit Suisse AG1,438,255$2.83M0.00%00.0%Unchanged
Baillie Gifford & Co1,418,996$2.80M0.00%−220,900−13.5%Reduced
Millennium Management LLC1,167,641$2.30M0.00%−12,418−1.1%Reduced
Principal Financial Group Inc667,041$1.31M0.00%−694,819−51.0%Reduced
Macquarie Group Ltd226,875$447.0K0.00%00.0%Unchanged
KBC Group NV163,447$322.0K0.00%00.0%Unchanged
Oppenheimer & Co Inc117,689$231.6K0.00%+1,526+1.3%Added
D. E. Shaw & Co., Inc.78,829$155.3K0.00%−43,701−35.7%Reduced
Morgan Stanley77,152$151.8K0.00%−550−0.7%Reduced
Citadel Advisors LLC29,983$59.1K0.00%+29,983New
Envestnet Asset Management Inc27,841$54.8K0.00%−15,027−35.1%Reduced
Wells Fargo & Company15,919$31.3K0.00%−560−3.4%Reduced
LPL Financial LLC14,007$27.6K0.00%+1,650+13.4%Added
One68 Global Capital, LLC11,000$21.6K0.13%00.0%Unchanged
Geode Capital Management, LLC10,776$21.2K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.5,365$10.6K0.00%−845−13.6%Reduced
National Bank of Canada3,600$7.01K0.00%00.0%Unchanged
Rhumbline Advisers2,970$5.85K0.00%+2,970New
BlackRock Inc.2,755$5.42K0.00%00.0%Unchanged
Assetmark, Inc2,721$5.35K0.00%+810+42.4%Added
BNP Paribas Arbitrage, SA1,217$2.39K0.00%+1,217New
JPMorgan Chase & Co519$1.02K0.00%−822−61.3%Reduced
Parallel Advisors, LLC500$9840.00%+500New
TD Waterhouse Canada Inc.360$7020.00%00.0%Unchanged
Russell Investments Group, Ltd.98$1930.00%+98New
Tower Research Capital LLC (TRC)45$890.00%+45New
Barclays PLC28$550.00%00.0%Unchanged
EverSource Wealth Advisors, LLC13$260.00%00.0%Unchanged
Bank of America Corp2$40.00%−9,153−100.0%Reduced
Sofos Investments, Inc.2$20.00%00.0%Unchanged
Toronto Dominion Bank31$00.00%00.0%Unchanged
Royal Bank of Canada56$00.00%−9−13.8%Reduced
Ronald Blue Trust, Inc.48$00.00%+48New
CVI Holdings, LLC0$00.00%−129,434−100.0%Sold out
Jane Street Group, LLC0$00.00%−50,522−100.0%Sold out
Vontobel Holding Ltd.0$00.00%−30,000−100.0%Sold out
Old Mission Capital LLC0$00.00%−22,329−100.0%Sold out
UBS Group AG0$00.00%−330−100.0%Sold out